Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 42

1.

Neoadjuvant therapy for treatment of breast cancer: the way forward, or simply a convenient option for patients?

Chatterjee A, Erban JK.

Gland Surg. 2017 Feb;6(1):119-124. doi: 10.21037/gs.2016.08.07.

2.

Rapid Change in Mental Status in a Patient with Hypereosinophilia.

Wang H, Erban JK.

Case Rep Hematol. 2017;2017:6936709. doi: 10.1155/2017/6936709. Epub 2017 Jan 10.

3.

Promoting High-Quality Cancer Care and Equity Through Disciplinary Diversity in Team Composition.

Parsons SK, Fineberg IC, Lin M, Singer M, Tang M, Erban JK.

J Oncol Pract. 2016 Nov;12(11):1141-1147. Epub 2016 Oct 31.

PMID:
27577618
4.

Adjuvant ovarian suppression in premenopausal breast cancer.

Francis PA, Regan MM, Fleming GF, Láng I, Ciruelos E, Bellet M, Bonnefoi HR, Climent MA, Da Prada GA, Burstein HJ, Martino S, Davidson NE, Geyer CE Jr, Walley BA, Coleman R, Kerbrat P, Buchholz S, Ingle JN, Winer EP, Rabaglio-Poretti M, Maibach R, Ruepp B, Giobbie-Hurder A, Price KN, Colleoni M, Viale G, Coates AS, Goldhirsch A, Gelber RD; SOFT Investigators.; International Breast Cancer Study Group..

N Engl J Med. 2015 Jan 29;372(5):436-46. doi: 10.1056/NEJMoa1412379. Epub 2014 Dec 11.

5.

Secondary pulmonary alveolar proteinosis in hematologic malignancies.

Chaulagain CP, Pilichowska M, Brinckerhoff L, Tabba M, Erban JK.

Hematol Oncol Stem Cell Ther. 2014 Dec;7(4):127-35. doi: 10.1016/j.hemonc.2014.09.003. Epub 2014 Oct 6. Review.

6.

Adjuvant exemestane with ovarian suppression in premenopausal breast cancer.

Pagani O, Regan MM, Walley BA, Fleming GF, Colleoni M, Láng I, Gomez HL, Tondini C, Burstein HJ, Perez EA, Ciruelos E, Stearns V, Bonnefoi HR, Martino S, Geyer CE Jr, Pinotti G, Puglisi F, Crivellari D, Ruhstaller T, Winer EP, Rabaglio-Poretti M, Maibach R, Ruepp B, Giobbie-Hurder A, Price KN, Bernhard J, Luo W, Ribi K, Viale G, Coates AS, Gelber RD, Goldhirsch A, Francis PA; TEXT and SOFT Investigators.; International Breast Cancer Study Group..

N Engl J Med. 2014 Jul 10;371(2):107-18. doi: 10.1056/NEJMoa1404037. Epub 2014 Jun 1.

7.

A proposal for integrated efficacy-to-effectiveness (E2E) clinical trials.

Selker HP, Oye KA, Eichler HG, Stockbridge NL, Mehta CR, Kaitin KI, McElwee NE, Honig PK, Erban JK, D'Agostino RB.

Clin Pharmacol Ther. 2014 Feb;95(2):147-53. doi: 10.1038/clpt.2013.177. Epub 2013 Sep 23.

8.

Invasive breast cancer.

Carlson RW, Allred DC, Anderson BO, Burstein HJ, Carter WB, Edge SB, Erban JK, Farrar WB, Forero A, Giordano SH, Goldstein LJ, Gradishar WJ, Hayes DF, Hudis CA, Ljung BM, Mankoff DA, Marcom PK, Mayer IA, McCormick B, Pierce LJ, Reed EC, Sachdev J, Smith ML, Somlo G, Ward JH, Wolff AC, Zellars R; National Comprehensive Cancer Network..

J Natl Compr Canc Netw. 2011 Feb;9(2):136-222. No abstract available.

PMID:
21310842
9.

Menstrual history and quality-of-life outcomes in women with node-positive breast cancer treated with adjuvant therapy on the NSABP B-30 trial.

Ganz PA, Land SR, Geyer CE Jr, Cecchini RS, Costantino JP, Pajon ER, Fehrenbacher L, Atkins JN, Polikoff JA, Vogel VG, Erban JK, Livingston RB, Perez EA, Mamounas EP, Wolmark N, Swain SM.

J Clin Oncol. 2011 Mar 20;29(9):1110-6. doi: 10.1200/JCO.2010.29.7689. Epub 2011 Feb 7.

10.

Breast cancer: noninvasive and special situations.

Carlson RW, Allred DC, Anderson BO, Burstein HJ, Carter WB, Edge SB, Erban JK, Farrar WB, Forero A, Giordano SH, Goldstein LJ, Gradishar WJ, Hayes DF, Hudis CA, Ljung BM, Marcom PK, Mayer IA, McCormick B, Pierce LJ, Reed EC, Smith ML, Somlo G, Topham NS, Ward JH, Winer EP, Wolff AC.

J Natl Compr Canc Netw. 2010 Oct;8(10):1182-207. No abstract available.

PMID:
20971842
11.

Longer therapy, iatrogenic amenorrhea, and survival in early breast cancer.

Swain SM, Jeong JH, Geyer CE Jr, Costantino JP, Pajon ER, Fehrenbacher L, Atkins JN, Polikoff J, Vogel VG, Erban JK, Rastogi P, Livingston RB, Perez EA, Mamounas EP, Land SR, Ganz PA, Wolmark N.

N Engl J Med. 2010 Jun 3;362(22):2053-65. doi: 10.1056/NEJMoa0909638.

12.

Breast cancer. Clinical practice guidelines in oncology.

Carlson RW, Allred DC, Anderson BO, Burstein HJ, Carter WB, Edge SB, Erban JK, Farrar WB, Goldstein LJ, Gradishar WJ, Hayes DF, Hudis CA, Jahanzeb M, Kiel K, Ljung BM, Marcom PK, Mayer IA, McCormick B, Nabell LM, Pierce LJ, Reed EC, Smith ML, Somlo G, Theriault RL, Topham NS, Ward JH, Winer EP, Wolff AC; NCCN Breast Cancer Clinical Practice Guidelines Panel..

J Natl Compr Canc Netw. 2009 Feb;7(2):122-92. Review. No abstract available.

PMID:
19200416
13.

Premenopausal endocrine-responsive early breast cancer: who receives chemotherapy?

Regan MM, Pagani O, Walley B, Torrisi R, Perez EA, Francis P, Fleming GF, Price KN, Thürlimann B, Maibach R, Castiglione-Gertsch M, Coates AS, Goldhirsch A, Gelber RD; SOFT/TEXT/PERCHE Steering Committee.; International Breast Cancer Study Group..

Ann Oncol. 2008 Jul;19(7):1231-41. doi: 10.1093/annonc/mdn037. Epub 2008 Mar 5.

PMID:
18325918
15.

Autoimmune hemolytic anemia in patients with liver transplants for primary biliary cirrhosis: Three case reports and a review of the literature.

Retana AK, Kaplan MM, Erban JK.

Am J Gastroenterol. 2007 Jan;102(1):197-200. Epub 2006 Oct 13. Review.

PMID:
17037996
16.

On the toxicity of chemotherapy for breast cancer--the need for vigilance.

Erban JK, Lau J.

J Natl Cancer Inst. 2006 Aug 16;98(16):1096-7. No abstract available.

PMID:
16912256
17.

Letrozole or tamoxifen in early breast cancer.

Erban JK.

N Engl J Med. 2006 Apr 6;354(14):1528-30; author reply 1528-30. No abstract available.

PMID:
16602148
18.
19.

Phase II study of interferon gamma in malignant carcinoid tumors (E9292): a trial of the Eastern Cooperative Oncology Group.

Stuart K, Levy DE, Anderson T, Axiotis CA, Dutcher JP, Eisenberg A, Erban JK, Benson III AB; Eastern Cooperative Oncology Group..

Invest New Drugs. 2004 Jan;22(1):75-81.

PMID:
14707497
20.

Screening for the risk for bleeding or thrombosis.

Eckman MH, Erban JK, Singh SK, Kao GS.

Ann Intern Med. 2003 Feb 4;138(3):W15-24. Review.

PMID:
12558384

Supplemental Content

Loading ...
Support Center